Infertility Among African American Women With Systemic Lupus Erythematosus Compared to Healthy Women: A Pilot Study
- PMID: 31282105
- PMCID: PMC6946885
- DOI: 10.1002/acr.24022
Infertility Among African American Women With Systemic Lupus Erythematosus Compared to Healthy Women: A Pilot Study
Abstract
Objective: Some treatments for systemic lupus erythematosus (SLE) can cause infertility, but the effect of SLE itself on fertility, particularly in African American women, is less clear. We undertook this study to examine infertility experiences in African American women with SLE compared to healthy women.
Methods: We enrolled women ages 22-40 years living in the Atlanta metropolitan area who were diagnosed with SLE after age 17 years. Women who had ever been treated with cyclophosphamide or who had a hysterectomy were excluded. African American women ages 22-40 years who were from the same area and recruited from a marketing list were used for comparison. Women were interviewed about their reproductive histories and goals. Periods of infertility were identified as times when women had regular, unprotected sex for ≥12 months without conceiving after 20 years of age. We separately considered any period of infertility and periods of infertility when attempting pregnancy. We used Cox proportional hazards regression to examine the association between SLE and time to infertility. Models were adjusted for age, nulliparity, and smoking. An age-matched analysis was also conducted to examine periods of infertility occurring after SLE diagnosis.
Results: Our sample included 75 women with SLE and 154 women without SLE. SLE was associated with any infertility (adjusted hazard ratio [HRadj ] 2.08 [95% confidence interval (95% CI) 1.38-3.15]), but less so with infertility when attempting pregnancy (HRadj 1.30 [95% CI 0.62-2.71]). The matched analysis generated similar point estimates.
Conclusion: Women with SLE may be more likely to experience episodes of infertility, but this may not translate to an inability to meet reproductive goals.
© 2019, American College of Rheumatology.
Conflict of interest statement
The authors report no conflicts of interest.
Figures
Similar articles
-
Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.Lupus Sci Med. 2020 Nov;7(1):e000439. doi: 10.1136/lupus-2020-000439. Lupus Sci Med. 2020. PMID: 33132225 Free PMC article.
-
Health service utilization among African American women living with systemic lupus erythematosus: perceived impacts of a self-management intervention.Arthritis Res Ther. 2019 Jun 25;21(1):155. doi: 10.1186/s13075-019-1942-7. Arthritis Res Ther. 2019. PMID: 31238992 Free PMC article. Clinical Trial.
-
Adverse Perinatal Outcomes Before and After Diagnosis of Systemic Lupus Erythematosus Among African American Women.Arthritis Care Res (Hoboken). 2022 Jun;74(6):904-911. doi: 10.1002/acr.24848. Epub 2022 Apr 5. Arthritis Care Res (Hoboken). 2022. PMID: 34931482 Free PMC article.
-
Causes and management of infertility in systemic lupus erythematosus.Rheumatology (Oxford). 2011 Sep;50(9):1551-8. doi: 10.1093/rheumatology/ker105. Epub 2011 Jun 7. Rheumatology (Oxford). 2011. PMID: 21652585 Review.
-
Impact of Systemic Lupus Erythematosus on Conception: Insights into Infertility, Fertility Preservation, Assisted Reproductive Technology, and Pregnancy Outcomes.Semin Reprod Med. 2024 Sep;42(3):209-227. doi: 10.1055/s-0044-1793827. Epub 2024 Dec 12. Semin Reprod Med. 2024. PMID: 39667369 Free PMC article. Review.
Cited by
-
Evaluation of the Ovarian Reserve in Women With Systemic Lupus Erythematosus.J Family Reprod Health. 2021 Mar;15(1):38-44. doi: 10.18502/jfrh.v15i1.6076. J Family Reprod Health. 2021. PMID: 34429735 Free PMC article.
-
Learning to listen: how empathetic engagement with patients can help overcome reproductive injustice.Lupus Sci Med. 2020 Nov;7(1):e000455. doi: 10.1136/lupus-2020-000455. Lupus Sci Med. 2020. PMID: 33229364 Free PMC article. No abstract available.
-
Anti-Müllerian hormone in African-American women with systemic lupus erythematosus.Lupus Sci Med. 2020 Nov;7(1):e000439. doi: 10.1136/lupus-2020-000439. Lupus Sci Med. 2020. PMID: 33132225 Free PMC article.
References
-
- Andreoli L, Bertsias GK, Agmon-Levin N, Brown S, Cervera R, Costedoat-Chalumeau N, Doria A, Fischer-Betz R, Forger F, Moraes-Fontes MF et al.: EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann Rheum Dis 2017, 76(3):476–485. - PMC - PubMed
-
- Lazzaroni MG, Dall’Ara F, Fredi M, Nalli C, Reggia R, Lojacono A, Ramazzotto F, Zatti S, Andreoli L, Tincani A: A comprehensive review of the clinical approach to pregnancy and systemic lupus erythematosus. J Autoimmun 2016, 74:106–117. - PubMed
-
- Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud K: Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2012, 64(5):668–674. - PubMed
-
- Vinet E, Clarke AE, Gordon C, Urowitz MB, Hanly JG, Pineau CA, Isenberg D, Rahman A, Wallace D, Alarcon GS et al.: Decreased live births in women with systemic lupus erythematosus. Arthritis Care Res (Hoboken) 2011, 63(7):1068–1072. - PubMed
-
- Clowse ME, Harward L, Criscione-Schreiber L, Pisetsky D, Copland S: Anti-Mullerian hormone: a better marker of ovarian damage from cyclophosphamide. Arthritis Rheum 2012, 64(5):1305–1310. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical